Health Care • Medical/Nursing Services
$5.93 ▼ -0.10
(-1.66%)
MKT CAP: $808.5M • VOL: 2.08M
52W L $5 52W H $13
AHCO // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $3.24B | $3.26B | $3.20B |
| YoY Revenue Growth % | -0.5% | +1.9% | — |
| Gross Profit | $609.2M | $681.1M | — |
| Gross Margin % | 18.8% | 20.9% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $90.9M | $263.7M | -$598.4M |
| Operating Margin % | 2.8% | 8.1% | -18.7% |
| Net Income (GAAP) | -$70.8M | $90.4M | -$678.9M |
| EBITDA (Normalized) | $396.8M | $508.6M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $601.8M | $541.8M | $480.7M |
| Capital Expenditures (CapEx) | $382.4M | $306.1M | — |
| Free Cash Flow (FCF) | $219.4M | $235.8M | $480.7M |
| FCF Margin % | 6.8% | 7.2% | 15.0% |
| Return on Invested Capital (ROIC %) | 2.2% | 5.9% | — |
| Cash & Short-Term Equivalents | — | — | — |
| Total Debt (Short + Long Term) | $1.72B | $1.96B | — |
| Total Stockholders' Equity | $1.52B | $1.57B | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR AHCO.